Chagas disease: clinical aspects and treatment in non-endemic countries;Maladie de Chagas : formes cliniques et prise en charge en zone non endémique

Presse Medicale

Volumn 38, Issue 11, 2009, Pages 1654-1666

  Le Loup, Guillaume ^a   Lescure, Francois Xavier ^a   Develoux, Michel ^a,b   Pialoux, Gilles ^a  

^a HÔPITAL TENON   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; NIFURTIMOX; POSACONAZOLE;

CHAGAS DISEASE; CLINICAL FEATURE; DISEASE COURSE; ENDEMIC DISEASE; HUMAN; IMMUNE DEFICIENCY; PARASITE VIRULENCE; PATIENT MONITORING; POLYMERASE CHAIN REACTION; POPULATION MIGRATION; PREGNANCY; SEROLOGY; SHORT SURVEY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; ARTICLE; CLINICAL PROTOCOL;

CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; CLINICAL PROTOCOLS; HUMANS;

EID: 71549152844     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2009.01.015     Document Type: Short Survey

References (39)

1. PAHO, SOPERJ. Update of american trypanosomiasis and leishmaniasis research and control. Final Report. Rio de Janeiro, Brazil, 6-7 november 2007; http://www.paho.org/English/ad/dpc/cd/res-dch-leish-priorities.pdf.
2. Schmunis G.A. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 102 Suppl 1 (2007) 75-85
3. Schofield C.J., Jannin J., and Salvatella R. The future of Chagas disease control. Trends Parasitol 22 (2006) 583-588
4. Lescure F.X., Canestri A., Melliez H., Jauréguiberry S., Develoux M., Dorent R., et al. Chagas disease, France. Emerg Infect Dis 14 (2008) 644-646
5. Lescure F.X., Jauréguiberry S., Jeannel D., Gay F., Develoux M., Le Loup G., et al. L'émergence de la trypanosomose humaine américaine (maladie de Chagas) se confirme en France métropolitaine. BEH 23-24 (2008) 220-221
6. Maguire J.H. Chagas disease : clinical features, diagnosis and treatment. In: Gilles H.M. (Ed). Protozoal diseases (1999), Arnold publishers, London
7. Kirchoff L.V. American trypanosomiasis. In: Guerrant R.L., Walker D.H., and Weller P.F. (Eds). Tropical infectious diseases : principles, pathogens and practice (2006), Churchill Livingstone, Philadelphia 1082-1094
8. Parada H., Carrasco H.A., Anez N., Fuenmayor C., and Inglessis I. Cardiac involvement is a constant finding in acute Chagas' disease : a clinical, parasitological and histopathological study. Int J Cardiol 60 (1997) 49-54
9. Prata A. Clinical and epidemiological aspects of Chagas diseases. Lancet Infect Dis 1 (2001) 92-100
10. Flores-Chavez M., Fernandez B., Puente S., Torres P., Rodriguez M., Monedero C., et al. Transfusional Chagas disease : parasitological and serological monitoring of a infected recipient and blood donor. Clin Infect Dis 46 (2008) e44-e47
11. Carlier Y. Maladie de Chagas congénitale : du laboratoire à la santé publique. Bull Mem Acad R Med Belg 162 (2007) 409-416
12. WHO. Control of Chagas disease. Technical Report Series 905.Geneva, Swiss, World Health Organization, 2002.
13. Kerleguer A., Massard S., Janus G., and Joussemer M. La maladie de Chagas : évaluation des tests de dépistage au centre de transfusion sanguine des armées, prévalence dans les armées. Pathol Biol 55 (2007) 534-538
14. Marin Neto J.A., Almeida Filho O.C., Pazin-Filho A., and Maciel B.C. Indeterminate form of Chags disease. Proposal of new diagnostic criteria and perspective for early treatment of cardiomyopathy. Arq Bras Cardiol 79 (2002) 623-627
15. Dutra W.O., and Gollob K.S. Current concepts in immunoregulation and pathology of human Chagas disease. Current Opin Infect Dis 21 (2008) 287-292
16. Gironès N., and Fresno M. Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence or both?. Trends Parasitol (2003) 19-22
17. Marin-Neto J.A., Cunha-Neto E., Maciel B.C., and Simões M.V. Pathogenesis of chronic Chagas heart disease. Circulation 115 (2007) 1109-1123
18. Rocha M.O., Teixeira M.M., and Ribeiro A.L. An update on the management of Chagas cardiomyopathy. Expert Rev Anti Infect Ther 5 (2007) 727-743
19. Acquatella H. Echocardiography in Chagas heart disease. Circulation 115 (2007) 1124-1131
20. Oliveira-Filho J., Viana L.C., Vieira-de-Melo R.M., Faiçal F., Torreão J.A., Villar F.A., et al. Chagas disease is an independant risk factor for stroke : baseline characteristics of a Chagas Disease cohort. Stroke 36 (2005) 2015-2017
21. Rassi Jr. A., Rassi A., Little W.C., Xavier S.S., Rassi S.G., Rassi A.G., et al. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 355 (2006) 799-808
22. Oliveira R.B., Troncon L.E., Dantas R.O., and Menghelli U.G. Gastrointestinal manifestations of Chagas's disease. Am J Gastroenterol 93 (1998) 884-889
23. Martin-Davila P., Fortun J., Lopez-Velez R., Norman F., Montes de Oca M., Zamarron P., et al. Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin Microbiol Rev 21 (2008) 60-96
24. Riarte A., Luna C., Sabatiello R., Sinagra A., Schiavelli R., De Rissio A., et al. Chagas' disease in patients with kidney transplants : 7 years of experience 1989-1996. Clin Infect Dis 29 (1999) 561-567
25. Sartori A.M.C., Ibrahim K.Y., Nunes Westphalen L.V., Braz L.M.A., Oliveira Jr. O.C., Gakiya E., et al. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol 1001 (2007) 31-50
26. Coura J.R., and de Castro S.L. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 97 (2003) 3-24
27. Viotti R., and Vigliano C. Etiological treatment of chronic Chagas disease : neglected 'evidence' by evidence-based medicine. Expert Rev Anti Infect Ther 5 (2007) 717-726
28. De Andrade A.L., Zicker F., De Oliveira R.M., Almeida e Silva S., Luquetti A., Travassos L.R., et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 348 (1996) 1407-1413
29. Andrade A.L., Martelli C.M., Oliveira R.M., Silva S.A., Aires A.I., Soussumi L.M., et al. Short report : benznidazole efficacy among Trypanosoma cruzi-infected adolescents after a six-year follow-up. Am J Trop Med Hyg 71 (2004) 594-597
30. Sosa Estani S., Segura E.L., Ruiz A.M., Velasquez E., Porcel B.M., and Yampotis C. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease. Am J Trop Med Hyg 59 (1998) 526-529
31. Viotti R., Vigliano C., Lococo B., Bertocchi G., Petti M., Alvarez M.G., et al. Long-term cardiac outcomes of treating chronic Chagas disease with Benznidazole versus no treatment. Ann Intern Med 144 (2006) 724-734
32. Fabbro D.L., Streiger M.L., Arias E.D., Bizai M.L., del Barco M., and Amicone N.A. Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years : parasitological, serological and clinical evolution. Rev Soc Bras Med Trop 40 (2007) 1-10
33. Marin-Neto J.A., Rassis Jr. A., Morillo C.A., Avezum A., Connolly S.J., Sosa-Estani S., et al. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy : the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J 156 (2008) 37-43
34. Solari A., Ortoz S., Soto A., Arancibia C., Campillay R., Contreras M., et al. Treatment of Tripanozoma cruzi infected children with nifurtimox : a 3 year follow-up by PCR. J Antimicrob Chemother 48 (2001) 515-519
35. Galvão S.M., Chiari E., Macedo A.M., Luquetti A.O., Silva S.A., and Andrade A.L. PCR assay for monitoring Trypanosoma cruzy parasitaemia in childhood after specific chemotherapy. J Clin Microbiol 41 (2003) 5066-5070
36. Bern C., Montgomery S.P., Herwaldt B.L., Rassi Jr. A., Marin-Neto J.A., Dantas R.O., et al. Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA 298 (2007) 2171-2181
37. Ministério da Saúde. Secretaria de Vigilância em Saúde. Consenso Brasileiro de Doencça de Chagas. Rev Soc Bras Med Trop 38 Suppl 3 (2005) 1-29
38. Botoni F.A., Poole-Wilson P.A., Ribeiro A.L., Okonko D.O., Oliveira B.M., Pinto A.S., et al. A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy. Am Heart J 153 (2007) 544.e1-544.e8
39. Rassi Jr. A., Rassi A., and Rassi S.G. Predictors of mortality in chronic Chagas disease: a systematic review of observationnal studies. Circulation 115 (2007) 1101-1108